Related Experiment Video
Updated: Jun 30, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Faecal microbiota transplantation for eradicating Helicobacter pylori infection: clinical practice and theoretical
Zhi-Ning Ye1, Guy D Eslick2, Shao-Gang Huang3
1The Affiliated Dongguan Hospital of Guangzhou University of Chinese Medicine, Dongguan, China.
Abstract:
The sustained increase in antibiotic resistance leads to a declining trend in the eradication rate of Helicobacter pylori (H. pylori) infection with antibiotic-based eradication regimens. Administration of a single probiotic shows limited efficacy in eradicating H. pylori infection. This review indicates that faecal microbiota transplantation (FMT), a novel therapeutic approach, either as a monotherapy or adjunctive therapy, exhibits beneficial effects in terms of the eradication of H. pylori infection and the prevention of adverse events. The role of FMT in H. pylori eradication may be associated directly or indirectly with some therapeutic constituents within the faecal suspension, including bacteria, viruses, antimicrobial peptides and metabolites. In addition, variations in donor selection, faecal suspension preparation and delivery methods are believed to be the main factors determining the effectiveness of FMT for the treatment of H. pylori infection. Future research should refine the operational procedures of FMT to achieve optimal efficacy for H. pylori infection and explore the mechanisms by which FMT acts against H. pylori.
Insights
Faecal microbiota transplantation (FMT) shows promise for eradicating Helicobacter pylori (H. pylori) infections, offering a new approach when antibiotics fail. Research is ongoing to optimize FMT protocols for maximum effectiveness against H. pylori.
Area of Science:
- Microbiology
- Gastroenterology
- Immunology
Background:
- Antibiotic resistance is decreasing the effectiveness of standard treatments for *Helicobacter pylori* (*H. pylori*) infections.
- Single probiotic administration has shown minimal success in eradicating *H. pylori*.
Purpose of the Study:
- To review the efficacy of faecal microbiota transplantation (FMT) as a therapeutic strategy for *H. pylori* eradication.
- To explore the potential mechanisms and influencing factors of FMT in treating *H. pylori* infection.
Main Methods:
- Review of existing literature on FMT for *H. pylori* eradication.
- Analysis of FMT's role as monotherapy and adjunctive therapy.
Main Results:
- FMT demonstrates beneficial effects in eradicating *H. pylori* and preventing adverse events.
- The efficacy of FMT may be attributed to various components within the fecal suspension, such as microbes and metabolites.
- Donor selection, preparation, and delivery methods significantly impact FMT effectiveness.
Conclusions:
- FMT presents a promising therapeutic option for *H. pylori* infection, particularly in the context of rising antibiotic resistance.
- Further research is needed to optimize FMT procedures and elucidate its precise mechanisms of action against *H. pylori*.
Related Concept Videos
What is Monogastric Digestion?
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

